KARI CELAYA: Open Payments
NPI 1588830392 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 13 payments from 9 companies in 2025. Trend: 2023 $130 · 2024 $244 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $128 |
| PFIZER INC. | 1 | $105 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $70 |
| CARDIVA MEDICAL, INC. | 1 | $36 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Abbott Laboratories | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: VYNDAQEL, CAMZYOS, LifeVest, OPTOWIRE, ELIQUIS, VERQUVO, AVEIR, AMVUTTRA.
Industry payments across AZ — which companies pay providers there.
